Production (Stage)
Bright Minds Biosciences Inc.
DRUG
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 38.74M | 40.24M | 4.23M | 4.52M | 4.38M |
| Total Receivables | 162.50K | 46.60K | 37.20K | 12.60K | 408.60K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 279.30K | 179.30K | 160.40K | 42.60K | 11.30K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 39.18M | 40.46M | 4.43M | 4.58M | 4.80M |
|
|
|||||
| Total Current Assets | 39.18M | 40.46M | 4.43M | 4.58M | 4.80M |
| Net Property, Plant & Equipment | 107.50K | 123.00K | 87.10K | 8.80K | 22.30K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 39.29M | 40.59M | 4.52M | 4.59M | 4.82M |
|
|
|||||
| Total Accounts Payable | 383.50K | 259.70K | 301.70K | 109.30K | 591.60K |
| Total Accrued Expenses | 6.30K | 10.60K | 30.90K | 11.00K | 7.40K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 54.10K | 50.50K | 58.80K | 10.20K | 25.60K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 443.80K | 320.80K | 391.30K | 130.50K | 624.60K |
|
|
|||||
| Total Current Liabilities | 443.80K | 320.80K | 391.30K | 130.50K | 624.60K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 61.80K | 76.50K | 29.30K | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 505.70K | 397.30K | 420.60K | 130.50K | 624.60K |
|
|
|||||
| Common Stock & APIC | 62.54M | 61.87M | 26.22M | 25.61M | 25.88M |
| Retained Earnings | -25.92M | -23.84M | -25.43M | -24.53M | -24.96M |
| Treasury Stock & Other | 2.15M | 2.16M | 3.30M | 3.38M | 3.28M |
| Total Common Equity | 38.78M | 40.19M | 4.10M | 4.46M | 4.20M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 38.78M | 40.19M | 4.10M | 4.46M | 4.20M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 38.78M | 40.19M | 4.10M | 4.46M | 4.20M |
|
|
|||||